SemperVirens Venture Capital Welcomes New CFO
Henri Cournand has officially joined SemperVirens as the Chief Financial Officer. His primary goal is to strengthen the company's financial strategy while supporting its growth in the areas of health, wealth, and work.
Henri Cournand's Background and Experience
Cournand brings with him an impressive career that spans over 17 years, with significant time spent at Cigna. Most recently, he held the position of Senior Vice President and CFO at Blue Cross Blue Shield of Kansas City. Additionally, he has experience leading Cobalt Ventures, a strategic Limited Partner of SemperVirens. His extensive background in financial leadership is expected to greatly benefit SemperVirens as the firm seeks to expand its involvement in the healthcare sector.
Key Initiatives for Cournand as CFO
In his new position, Cournand will lead several important initiatives, including the integration of best practices into the firm’s financial operations and guiding the SV Healthcare Executive Advisory group. He will also focus on identifying new strategic partnerships to enhance the firm’s network.
Working with Portfolio Companies
Collaboration is central to Cournand’s approach; he intends to partner closely with portfolio companies in the healthcare and benefits sectors through the SemperSystem™. This strategy aims to unlock ecosystem values and drive revenue growth.
Insights from the CEO on the Appointment
Stephan Roche, the CEO of SemperVirens, shared his enthusiasm about Cournand's appointment, stating, "Henri's extensive financial expertise and leadership experience make him a fantastic addition to our team. His knowledge will be crucial as we continue to scale our investments in the next generation of companies that are transforming healthcare, all while working towards our mission of reshaping the worlds of health, wealth, and work."
About SemperVirens
Founded in 2018, SemperVirens is a dedicated venture capital firm that focuses on tech startups innovating at the intersection of employer and employee relations in health, wealth, and work. The firm employs a unique value creation model that empowers portfolio companies to drive revenue growth through a proprietary network of employers, strategic distribution partners, CHRO advisors, and investors. With over $300 million in assets under management, SemperVirens currently boasts a diverse portfolio of 65 dynamic companies.
Frequently Asked Questions
Who is Henri Cournand?
Henri Cournand is the newly appointed Chief Financial Officer of SemperVirens Venture Capital, bringing extensive experience from his prior roles at Cigna and Blue Cross Blue Shield.
What are Cournand's main responsibilities as CFO?
His main responsibilities include enhancing financial practices, leading the SV Healthcare Executive Advisory group, and forging strategic partnerships.
What is the mission of SemperVirens?
The mission of SemperVirens is to reshape the realms of health, wealth, and work by investing in innovative tech startups.
How long has SemperVirens been operating?
SemperVirens was launched in 2018, focusing on impactful ventures in critical sectors.
What industries does SemperVirens focus on?
SemperVirens primarily invests in technology companies that influence employee health, wealth, and workplace dynamics.
